Navigation Links
Site in Biological Technology

One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions

... Launch Of Its New And Improved Website. The New site Provides Users With A Comprehensive Overview Of ... To Enhance Functionality And Navigation. The site Also Offers An Expanded Service Description For ... launch of its new and improved website. The new site provides users with a comprehensive overview of ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. Amicus' press releases are ...

ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12

... investor relations section of the Company's Web site at www.adventrx.com . A 48-hour ... webcast will be available on the Company's Web site for 14 days following the completion of the call. ... information can be found on the Company's web site at www.adventrx.com . ...

AIAG and MichBio Form New Collaborative Partnership

... AIAG's initiatives visit the organization's Web site at www.aiag.org . About AIAG AIAG is a ... information, please visit the organization's Web site at www.aiag.org . About MichBio MichBio is ... information, please visit the organization's Web site at www.michbio.org . ### Read the full ...

ERT Reports Second Quarter 2009 Results

... Financial and can be accessed at ERT's web site at www.ert.com . The webcast may also be ... 26,763 16,215 51,358 32,323 site support 7,222 6,878 ... 10,185 7,671 20,448 15,364 Cost of site support 4,599 3,470 9,867 ...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... level of protein synthesis at a specific site in the body and can be used in soft tissue such ... of DNA-driven proteins at the injury site within a Gene Activated Matrix offers the ... improve healing. Harvesting bone from a second site to augment healing has been the gold standard but ...

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

... and HeartWare with the SEC at the SEC's web site at http://www.sec.gov. The proxy ... are available free of charge at the SEC's web site at www.sec.gov or by contacting HeartWare ... is available free of charge at the SEC's web site at www.sec.gov or by going to Thoratec's ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date

... investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. Amicus' press releases are ...

Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results

... webcast can be accessed from Varian, Inc.'s Web site at www.varianinc.com . Go to ... webcast will be available on Varian, Inc.'s Web site for at least 90 days. Varian, Inc. is a ... information is available on the company's Web site at http://www.varianinc.com . ...

4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.

... chain. The final highlight to the event will be a site visit to the Biomass CHP Gussing Plant. ... To complete the program, an optional half-day site visit to the Biomass CHP Plant in Güssing, ... diesel, which will be showcased at the site visit tour. 4th BTLtec builds on the globally ...

American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals

... of America. Allergy Facts and Figures. Web site accessed May 1, 2009: ... Allergic Diseases Resource Center. Web site accessed May 26, 2009: ... as a basis for effective treatment." Web site accessed July 1, 2009: ...

I Walk Because Program Gives Consumers a Voice

... component of the "I Walk Because" program. The site delivers a personalized user experience through ... for others in the MS community. To keep the site active, registered users also receive a series of emails inviting them back to the site to view content from other walk participants and ...

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives

... (66 percent) and producing less injection site reactions (56 percent). "When we examine the ... pain and discomfort they receive at the injection site as well as tolerance issues as drawbacks from ... company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . ...

Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy

... an in situ remedial design for a large, complex site located inside an operating petrochemical plant ... Northern Italy. The subsurface environment at the site is impacted by 1,2-dichloroethane (1,2-DCA) and ... 1,2-DCA. CONCLUSIONS Design of full-scale site remediation using the EHC ISCR technology is ...

New Stem Cell Web Site to Focus on Traumatic Brain Injury, Spinal Cord Injury and Diabetes

... BMSN) announced today the launch of its Web site ( http://www.EntestBio.com ) to focus on new ... the U.S. suffer from this disability. The site also highlights the Company's progress in ... about types of stem cells and factoids, the new site also reviews Entest BioMedical's focus on the ...

ERT Reports First Quarter 2009 Results

... Financial and can be accessed at ERT's web site at www.ert.com . The webcast may also be ... 25,273 16,817 site support 7,775 ... 10,514 7,954 Cost of site support 5,268 ...

Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date

... investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. Amicus' press releases are ...

Bio Career Center Becomes Top in Nation for Life Sciences Careers

... time and shorten the hiring process. The site has become an industry leader because it offers ... needs. "Since all of the candidates on our site are postgraduate life scientists and M.D.s, we know they have a passion for science," said site founder Nick Folger. "More than 40 percent of our ...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

... In addition, a lower incidence of injection site reactions observed with SparVax(TM) may suggest ... proportion of individuals experiencing injection site pain in the BioThrax(R) group as compared to the ... product. The lower incidence of injection site reactions observed with SparVax(TM) may indicate ...

Hovione Opens its New API Plant in Cork

... active pharmaceutical ingredient manufacturing site in Cork. Hovione contracted with Pfizer last December to take over the site that had been manufacturing Lipitor(R) since ... developer and manufacturer and the Cork site will be used to produce active pharmaceutical ...

Varian, Inc. to Webcast Conference Call on Second Quarter Fiscal Year 2009 Financial Results

... webcast can be accessed from Varian, Inc.'s Web site at www.varianinc.com . Go to ... webcast will be available on Varian, Inc.'s Web site for at least 90 days. Varian, Inc. is a ... information is available on the company's Web site at http://www.varianinc.com . For ...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... percent of SIMPONI treated patients had injection site reactions compared with 2.2 percent in control-treated patients. The majority of the injection site reactions were mild and moderate, and the most ... company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . ...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables

... Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction with the ... Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction of the ... from the Investors section on the corporate web site at http://www.sinovac.com . A webcast replay ...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results

... Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction with the ... Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction of the ... from the Investors section on the corporate web site at http://www.sinovac.com . A webcast replay ...

Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA

... about BIOZONA 2009, please visit the event web site at http://www.azbio.org/Biozona2009.asp . ... Pharmatech Oncology provides services of a site Management Organization (SMO) and a Contract ... Trials, Cancer, Patients, Contract Research, site Management, Data Management, Research, Network, ...

Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge

... is Innocoll's lead technology platform for the site specific targeted delivery of a wide variety of ... III development for the prevention of surgical site infections in patients or surgeries at higher ... in the US for the prevention of surgical site infections. It is approved for sale in 49 ...

NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union

... treatment option applied directly to the site of pain, Qutenza can produce up to three months ... Investor Relations section on the corporate web site at http://www.neurogesx.com . A web cast replay can be accessed on the corporate web site beginning March 20, 2009 at the same time as the ...

The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor

... as a preferred vendor for its Contract Research, site Management, and Data Management services within ... Pharmatech Oncology provides services of a site Management Organization (SMO) and a Contract ... Trials, Cancer, Patients, Contract Research, site Management, Data Management, Research, Network, ...

Agencies Unite to Launch Donor Network Alliance: First-Ever Web-Based Collective of Egg Donor Candidates

... CHICAGO, March 10 /PRNewswire/ -- A new Web site has launched that facilitates the search for egg ... consuming for intended parents." The DNA Web site is the portal to a robust, searchable database of ... agency, which can be e-mailed directly from the site for further information. "It's all about ...

ERT Reports Fourth Quarter and Full Year 2008 Results

... Financial and can be accessed at ERT's web site at www.ert.com . The webcast may also be ... 21,565 21,748 69,547 99,258 site support 6,657 7,500 26,451 ... 8,749 30,522 39,697 Cost of site support 4,665 3,880 17,808 ...

Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results

... investor section of the Amicus Therapeutics Web site at http://www.amicustherapeutics.com under ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. A telephonic replay of the call ...

Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science

... - Buildings For Science - has launched a new web site - http://www.buildingsforscience.com/ The new ... edge. One very important element of the new web site is that it hosts an improved technical library, ... said, "The goal of Art's Way Scientifics' new web site is to provide a one-stop technology resource that ...

Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date

... investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under Investors: ... Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to ... Investors section of the Amicus Therapeutics Web site for 30 days. Amicus' press releases are ...

SAFC Pharma Augments Assay Development Capabilities

... announcement of a $12 million expansion at the site to construct two fully segregated manufacturing ... capacity within the current 44,000 sq. ft. site and is planned to be Biosafety Level 2 compliant, ... Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com . ...

International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"

... England, January 28 /PRNewswire/ -- The Binding site Limited ("The Binding Site" or the "Company"), a ... . About The Binding site The Binding site Ltd. is a British based company specialising in ...

Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55

... information, please refer to the Amgen Web site at www.amgen.com . As previously ... in the Investors section of the Company's Web site ( www.amgen.com/investors ) a slide presentation ... the Internet and can also be found on Amgen's Web site at the above web address. Non-GAAP ...

DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant

... device to significantly reduce surgical site infections (SSIs) and potentially save the ... technology designed to mitigate Surgical site Infections (SSIs) in spinal surgery. The ... of stopping biofilm formation in the bone graft site and eliminating 650 types of bacteria including ...

Life Sciences Organizations Choose Oracle to Accelerate and Simplify Clinical Trial Data Collection

... needs of trial sponsors as well as investigative site personnel by providing a simplified user interface and eliminating site software installation. This helps to increase ... information about Oracle, please visit our Web site at http://www.oracle.com . Trademarks ...

Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)

... through Abbott's Investor Relations Web site at http://www.abbottinvestor.com . About ... For more information, visit the company's Web site at http://www.amo-inc.com . About Abbott ... information are available on the company's Web site at http://www.abbott.com . Additional ...

Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)

... Draper Labs Acquires Manufacturing site in Tampa Bay The Charles Stark Draper ... St. N., should be completed in March 2009. The site could employ an estimated 65 people in the next ... including the HydroMARK, a breast biopsy site marker that helps patients by replacing lengthy ...
Other Contents
(Date:4/17/2014)... Researchers in France have hit on a novel ... receive the correct and most effective treatment possible., ... the western and developing world. If left untreated, ... to renal failure and other complications. In many ... problem. Clearly a more effective pathological approach to ...
(Date:4/17/2014)... Indiana University researchers have detected new early-warning signs of ... discovery could have far-reaching implications for the diagnosis and ... over 25 million Americans. , "We had not expected ... such early stages," said Ann Elsner, professor and associate ... author of the study. "We set out to study ...
(Date:4/17/2014)... have uncovered a new way the immune system may ... efforts to use immune cells to treat illness. , ... the immunological equivalent of "neighborhood police" specialized squads ... organ, instead of an entire city, the body. , ... Louis have shown that the liver, skin and uterus ...
Breaking Biology News(10 mins):New technique detects microscopic diabetes-related eye damage 2New technique detects microscopic diabetes-related eye damage 3Some immune cells defend only 1 organ 2
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... (April 17, 2014) Doctors who treat patients ... lymphangioleiomyomatosis (LAM) can face an agonizing treatment decision. ... the disease and help relieve shortness of breath. ... and sirolimus can cause potentially fatal complications following ... Dr. Daniel Dilling, medical director of Loyola University ...
(Date:4/17/2014)... (BUSM) have discovered that the anti-seizure drug ezogabine, ... findings, reported in the American Journal of ... more effective treatments for alcoholism. , Excessive consumption ... of illness and death in the U.S. and ... productivity of workers and necessitating huge health care ...
(Date:4/17/2014)... NEW YORK (17 April 2014) Population Council scientists and ... is safe, stable, and can prevent the transmission of ... and rectum in animals: HIV, herpes simplex virus 2 ... provides the first data that the gel is effective ... of efficacy in the vagina against all three viruses ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
Other TagsOther Tags